Linking SMN to SMA
An assay for the rescuer
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Spinal muscular atrophy (SMA) is the most common fatal genetic disorder of infancy with an estimated population carrier frequency of 1:37, an autosomal recessive pattern of inheritance, and an estimated incidence of 1:6,000 to 1:10,000 live births.1 The genomic region on 5q11-q13, in which the causative survival of motor neuron (SMN) gene was identified in 1995, is unusual in that it has undergone a complete inverted duplication, resulting in two copies of each gene contained in the duplication.2 Because this duplication occurred relatively recently in evolution, the two copies of the SMN gene are almost identical in sequence. Mutations in SMN1 are causative for the disease but its nearly identical duplicated version, SMN2, is also capable of making wild-type protein, i.e., its coding region is identical to SMN1. Importantly, a critical C to T base pair change at the SMN2 exon 7 splice donor site leads to exclusion of exon 7; this results in …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALSJ. H. Veldink, S. Kalmijn, A. H. Van der Hout et al.Neurology, August 10, 2005 -
Article
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophyRodrigo de Holanda Mendonça, Ciro Matsui, Jr, Graziela Jorge Polido et al.Neurology: Genetics, September 01, 2020 -
Articles
SMN1 gene, but not SMN2, is a risk factor for sporadic ALSP. Corcia, W. Camu, J. -M. Halimi et al.Neurology, August 23, 2006 -
Articles
Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domainM.J. Fraidakis, S. Drunat, T. Maisonobe et al.Neurology, February 08, 2012